JANE STREET GROUP, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 54 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$48,000
-85.5%
92,306
-78.9%
0.00%
Q2 2020$331,000
-0.3%
436,708
+115.6%
0.00%
-100.0%
Q2 2019$332,000
+1560.0%
202,580
+1682.6%
0.00%
Q1 2019$20,000
-78.3%
11,364
-74.4%
0.00%
Q2 2018$92,00044,3410.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders